Cor Vasa 2011, 53(11):649-653 | DOI: 10.33678/cor.2011.161

First experience with allogeneic homograft in the treatment of prosthetic endocarditis

František Sabol¹, Adrian Kolesár^1,*, Martin Beňa¹, Marta Jakubová³, Jaroslav Špatenka⁴, Ján Luczy¹, Branislav Stančák², Jana Jevčáková¹, Ingrid Schusterová¹

¹ Klinika srdcovej chirurgie, Lekárska fakulta UPJŠ a VÚSCH, a.s., Košice, SR

² Kardiologická klinika, Lekárska fakulta UPJŠ a VÚSCH, a.s., Košice, SR

³ Klinika anastézie a intenzívnej medicíny, Lekárska fakulta UPJŠ a VÚSCH, a.s., Košice, SR

⁴ Transplantační centrum Fakultní nemocnice v Motole, Praha, Česká republika

One of the possible complications after implantation of valve prostheses is the emergence of prosthetic endocarditis. It is a life-threatening complication, requiring complex and demanding treatment. One of the possible therapeutic modalities is using of allogeneic homograft. In this case report, we describe the case of 54-year-old hypertensive patient with incidentally discovered, asymptomatic aortic regurgitation and dilatation of the ascending aorta. We carried out planned replacement of the ascending aorta by a composite graft Bentall. The postoperative course was complicated by wound infection after sternotomy. Despite maximized antibiotic therapy, prosthetic endocarditis with periprosthetic abscess formation developed. Based on repeated positive cultivation and positive CT findings, reoperation was indicated, during which explanted composite graft was replaced by homograft. The postoperative course was uncomplicated and the patient was discharged for home treatment in a good condition. Based on literature data and our own experience, we believe that the treatment of prosthetic aortic valve endocarditis by homograft could be the method of choice.

Keywords: Homograft; Infective endocarditis

Published: November 1, 2011  Show citation